David Shapiro, CMO and EVP - Development at INTERCEPT PHARMACEUTICALS INC (ICPT), sold 1,116 shares at $108.51 ($121K) on 2017-04-10, disclosed to the SEC on 2017-04-11.
Seasonal sale ($121k) by CMO and EVP - Development — this insider has traded ICPT in April in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $108.51 | 558 | $61K | 50.0% |
| 2 | $108.51 | 558 | $61K | 50.0% |
| Total | $108.51 avg | 1,116 | $121K | 100% |
| Filing → |
| ICPT | SELL | 2019-04-03 | $129K | — | Filing → |
| ICPT | SELL | 2019-03-01 | $206K | — | Filing → |
| ICPT | SELL | 2019-02-20 | $223K | — | Filing → |